| BTS Clinical Statement on pulmonary sarcoidosis M Thillai, CP Atkins, A Crawshaw, SP Hart, LP Ho, V Kouranos, ... Thorax 76 (1), 4-20, 2021 | 106 | 2021 |
| Monoclonal antibodies for the treatment of refractory asthma N Hambly, P Nair Current opinion in pulmonary medicine 20 (1), 87-94, 2014 | 96 | 2014 |
| Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers? KA Johannson, I Strâmbu, C Ravaglia, JC Grutters, C Valenzuela, ... The Lancet Respiratory Medicine 5 (7), 591-598, 2017 | 88 | 2017 |
| Practical considerations for the diagnosis and treatment of fibrotic interstitial lung disease during the coronavirus disease 2019 pandemic AW Wong, L Fidler, V Marcoux, KA Johannson, D Assayag, JH Fisher, ... Chest 158 (3), 1069-1078, 2020 | 80 | 2020 |
| Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry N Hambly, MM Farooqi, A Dvorkin-Gheva, K Donohoe, K Garlick, ... European Respiratory Journal 60 (4), 2022 | 69 | 2022 |
| Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis JH Fisher, M Kolb, M Algamdi, J Morisset, KA Johannson, S Shapera, ... BMC pulmonary medicine 19, 1-9, 2019 | 64 | 2019 |
| Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkers N Hambly, C Shimbori, M Kolb Respirology 20 (7), 1010-1022, 2015 | 63 | 2015 |
| The Canadian Registry for Pulmonary Fibrosis: design and rationale of a national pulmonary fibrosis registry CJ Ryerson, B Tan, CD Fell, H Manganas, S Shapera, S Mittoo, ... Canadian respiratory journal 2016, 2016 | 60 | 2016 |
| Macitentan reduces progression of TGF-β1-induced pulmonary fibrosis and pulmonary hypertension PS Bellaye, T Yanagihara, E Granton, S Sato, C Shimbori, C Upagupta, ... European Respiratory Journal 52 (2), 2018 | 55 | 2018 |
| High oxygen delivery to preserve exercise capacity in patients with idiopathic pulmonary fibrosis treated with nintedanib. Methodology of the HOPE-IPF study CJ Ryerson, PG Camp, ND Eves, M Schaeffer, N Syed, S Dhillon, ... Annals of the American Thoracic Society 13 (9), 1640-1647, 2016 | 40 | 2016 |
| Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease APY Tsai, S Am Hur, A Wong, M Safavi, D Assayag, KA Johannson, ... Thorax 76 (1), 37-43, 2021 | 33 | 2021 |
| Pulmonary hypertension: diagnostic approach and optimal management N Hambly, F Alawfi, S Mehta CMAJ 188 (11), 804-812, 2016 | 30 | 2016 |
| Association of BMI and change in weight with mortality in patients with fibrotic interstitial lung disease A Comes, AW Wong, JH Fisher, J Morisset, KA Johannson, E Farrand, ... Chest 161 (5), 1320-1329, 2022 | 29* | 2022 |
| Riociguat for the treatment of pulmonary hypertension N Hambly, J Granton Expert review of respiratory medicine 9 (6), 679-695, 2015 | 25 | 2015 |
| Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study SA Guler, S Am Hur, MK Stickland, P Brun, L Bovet, AE Holland, ... Thorax 77 (6), 589-595, 2022 | 24 | 2022 |
| A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease AW Wong, TY Lee, KA Johannson, D Assayag, J Morisset, CD Fell, ... Respiratory Research 21, 1-9, 2020 | 24 | 2020 |
| Prevalence and prognostic impact of physical frailty in interstitial lung disease: a prospective cohort study MAM Farooqi, S O'Hoski, S Goodwin, N Makhdami, A Aziz, G Cox, J Wald, ... Respirology 26 (7), 683-689, 2021 | 23 | 2021 |
| Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis A Sakkat, G Cox, N Khalidi, M Larche, K Beattie, EA Renzoni, N Morar, ... Respiratory Research 23 (1), 54, 2022 | 22 | 2022 |
| Costs of workplace productivity loss in patients with fibrotic interstitial lung disease M Algamdi, M Sadatsafavi, JH Fisher, J Morisset, KA Johannson, CD Fell, ... Chest 156 (5), 887-895, 2019 | 20 | 2019 |
| Travel distance to subspecialty clinic and outcomes in patients with fibrotic interstitial lung disease KA Johannson, BC Lethebe, D Assayag, JH Fisher, M Kolb, J Morisset, ... Annals of the American Thoracic Society 19 (1), 20-27, 2022 | 15 | 2022 |
